Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction

被引:0
|
作者
Seon-Soo Kim
Hyun-Jung Byun
Sang-Hoon Kim
Han-Hyoung Lee
Suk Jun Lee
Sang Joon Kim
Chung-Gyu Park
Taehoon Chun
机构
[1] Korea University,Division of Biotechnology, College of Life Sciences and Biotechnology
[2] Seoul National University College of Medicine,Department of Surgery
[3] Seoul National University,Department of Microbiology and Immunology, College of Medicine
来源
Biotechnology Letters | 2010年 / 32卷
关键词
Co-receptor; Lymphocyte activation gene-3; Mixed lymphocyte reaction; Pig; T cell activation; Xenogeneic response;
D O I
暂无
中图分类号
学科分类号
摘要
Lymphocyte activation gene-3 (LAG-3; CD223) is a transmembrane protein that is structurally similar to CD4. Since LAG-3 has a much higher binding affinity to MHC class II than that of CD4, several approaches using soluble LAG-3 were used to modulate immune responses by activation or inhibition of MHC class II expressing antigen presenting cells. In this study, we constructed soluble pig LAG-3 containing a critical binding site (D1 and D2 region) to MHC class II molecules, combined with a constant region of an immunoglobulin (Ig) heavy chain. Flow cytometry analyses indicated that soluble pig LAG-3 binds to both pig and human MHC class II molecules. Moreover, soluble pig LAG-3 can inhibit human lymphocyte proliferation in the human–pig xenogeneic mixed lymphocyte reaction in a dose-dependent manner. These results indicate that soluble pig LAG-3 may be useful for controlling the xenogeneic T cell immune responses between the human and pig.
引用
收藏
页码:203 / 208
页数:5
相关论文
共 50 条
  • [41] Phase 1 study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis
    Hamid, Omid
    Weise, Amy
    Lewis, Karl D.
    Kim, Tae Min
    McKean, Meredith
    Lakhani, Nehal J.
    Kaczmar, John
    Papadopoulos, Kyriakos P.
    Chen, Shuquan
    Mani, Jayakumar
    Gullo, Giuseppe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB207 - AB207
  • [42] The relationship between soluble lymphocyte activation gene-3 and coronary artery disease
    Xiong, Xinlin
    Duan, Zonggang
    Zhou, Haiyan
    Niu, Li
    Luo, Zhenhua
    Li, Wei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] Multitumor Profiling of Lymphocyte Activation Gene 3 (LAG-3) and Association with Immune Cell Phenotypes
    Edwards, R.
    Hedvat, C.
    Cogswell, J.
    Locke, D.
    Lee, G.
    Baxi, V.
    Vitazka, P.
    Szabo, P. M.
    Jin, C.
    Pandya, D.
    Desai, K.
    Meier, R.
    Maurer, M.
    Jackson, D.
    Ross-MacDonald, P.
    Wind-Rotolo, M.
    Saci, A.
    Mankoo, P.
    Bruey, J. M.
    Harbison, C.
    Selby, M.
    Korman, A.
    Thudium, K.
    Bao, R.
    Taube, J. M.
    Luke, J. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S1 - S1
  • [44] Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
    Kisielow, M
    Kisielow, J
    Capoferri-Sollami, G
    Karjalainen, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) : 2081 - 2088
  • [45] Lymphocyte-activation gene 3 (LAG-3) expression in the inflammatory microenvironment of glioma.
    Mair, Maximilian
    Kiesel, Barbara
    Feldmann, Katharina
    Widhalm, Georg
    Dieckmann, Karin
    Woehrer, Adelheid
    Muellauer, Leonhard
    Preusser, Matthias
    Berghoff, Anna Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Expression and Purification of the human Lymphocyte Activation Gene-3 for Structural Studies
    Rivera, Amilcar
    Zavala-Ruiz, Zarixia
    FASEB JOURNAL, 2010, 24
  • [47] Lymphocyte activation gene 3 (LAG-3) regulates activation-induced CD4+T cell metabolic transition
    Previte, Dana
    Delmastro-Greenwood, Meghan
    Piganelli, Jon
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [48] Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
    Annunziato, F
    Manetti, R
    Cosmi, L
    Galli, G
    Heusser, CH
    Romagnani, S
    Maggi, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) : 2239 - 2244
  • [49] Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T- cells to Be Suppressed In Vivo
    Durham, Nicholas M.
    Nirschl, Christopher J.
    Jackson, Christopher M.
    Elias, Jimmy
    Kochel, Christina M.
    Anders, Robert A.
    Drake, Charles G.
    PLOS ONE, 2014, 9 (11):
  • [50] CD4/MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INTERACTION ANALYZED WITH CD4 AND LYMPHOCYTE-ACTIVATION GENE-3 (LAG-3)-IG FUSION PROTEINS
    HUARD, B
    PRIGENT, P
    TOURNIER, M
    BRUNIQUEL, D
    TRIEBEL, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2718 - 2721